 | • レポートコード：MRC2312MG07521 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の臨床デジタル病理学市場規模と予測を収録しています。・世界の臨床デジタル病理学市場：売上、2018年-2023年、2024年-2029年 ・世界の臨床デジタル病理学市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の臨床デジタル病理学市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「全スライドイメージング（WSI）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 臨床デジタル病理学のグローバル主要企業は、Leica Biosystems、 ZEISS、 Hamamatsu Photonics、 3DHISTECH Ltd.、 OLYMPUS (EVIDENT)、 Philipes、 ROCHE、 KFBIO、 Motic、 Shengqiang、 Unic、 Winmedic、 Wisleapなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、臨床デジタル病理学のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の臨床デジタル病理学市場：タイプ別、2018年-2023年、2024年-2029年 世界の臨床デジタル病理学市場：タイプ別市場シェア、2022年 ・全スライドイメージング（WSI）、画像解析、その他 世界の臨床デジタル病理学市場：用途別、2018年-2023年、2024年-2029年 世界の臨床デジタル病理学市場：用途別市場シェア、2022年 ・病院、診断センター 世界の臨床デジタル病理学市場：地域・国別、2018年-2023年、2024年-2029年 世界の臨床デジタル病理学市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における臨床デジタル病理学のグローバル売上、2018年-2023年 ・主要企業における臨床デジタル病理学のグローバル売上シェア、2022年 ・主要企業における臨床デジタル病理学のグローバル販売量、2018年-2023年 ・主要企業における臨床デジタル病理学のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Leica Biosystems、 ZEISS、 Hamamatsu Photonics、 3DHISTECH Ltd.、 OLYMPUS (EVIDENT)、 Philipes、 ROCHE、 KFBIO、 Motic、 Shengqiang、 Unic、 Winmedic、 Wisleap ************************************************************* ・調査・分析レポートの概要 臨床デジタル病理学市場の定義 市場セグメント 世界の臨床デジタル病理学市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の臨床デジタル病理学市場規模 世界の臨床デジタル病理学市場規模：2022年 VS 2029年 世界の臨床デジタル病理学市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの臨床デジタル病理学の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の臨床デジタル病理学製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：全スライドイメージング（WSI）、画像解析、その他 臨床デジタル病理学のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診断センター 臨床デジタル病理学の用途別グローバル売上・予測 ・地域別市場分析 地域別臨床デジタル病理学市場規模 2022年と2029年 地域別臨床デジタル病理学売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Leica Biosystems、 ZEISS、 Hamamatsu Photonics、 3DHISTECH Ltd.、 OLYMPUS (EVIDENT)、 Philipes、 ROCHE、 KFBIO、 Motic、 Shengqiang、 Unic、 Winmedic、 Wisleap ... |
This research report provides a comprehensive analysis of the Clinical Digital Pathology market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Clinical Digital Pathology market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Clinical Digital Pathology, challenges faced by the industry, and potential opportunities for market players.
The global Clinical Digital Pathology market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Clinical Digital Pathology market presents opportunities for various stakeholders, including Hospital, Diagnostic Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Clinical Digital Pathology market. Additionally, the growing consumer demand present avenues for market expansion.
The global Clinical Digital Pathology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Whole slide imaging, which involves digitizing entire glass slides for remote viewing and analysis, is becoming more widely adopted in clinical pathology laboratories. It enables pathologists to work remotely, share images for consultations, and enhance collaboration.
AI and machine learning algorithms are increasingly being integrated into digital pathology solutions. These AI tools assist pathologists in image analysis, tumor detection, and disease classification, ultimately improving diagnostic accuracy and efficiency.
Key Features:
The research report on the Clinical Digital Pathology market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Clinical Digital Pathology market.
Market Overview: The report provides a comprehensive overview of the Clinical Digital Pathology market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Whole Slide Imaging (WSI), Image Analysis), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Clinical Digital Pathology market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Clinical Digital Pathology market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Clinical Digital Pathology market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Clinical Digital Pathology market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Clinical Digital Pathology market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Clinical Digital Pathology market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Clinical Digital Pathology, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Clinical Digital Pathology market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Clinical Digital Pathology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Whole Slide Imaging (WSI)
Image Analysis
Other
Market segment by Application
Hospital
Diagnostic Centers
Global Clinical Digital Pathology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Leica Biosystems
ZEISS
Hamamatsu Photonics
3DHISTECH Ltd.
OLYMPUS (EVIDENT)
Philipes
ROCHE
KFBIO
Motic
Shengqiang
Unic
Winmedic
Wisleap
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Digital Pathology, market overview.
Chapter 2: Global Clinical Digital Pathology market size in revenue.
Chapter 3: Detailed analysis of Clinical Digital Pathology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Digital Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Clinical Digital Pathology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Digital Pathology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Digital Pathology Overall Market Size
2.1 Global Clinical Digital Pathology Market Size: 2022 VS 2029
2.2 Global Clinical Digital Pathology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Digital Pathology Players in Global Market
3.2 Top Global Clinical Digital Pathology Companies Ranked by Revenue
3.3 Global Clinical Digital Pathology Revenue by Companies
3.4 Top 3 and Top 5 Clinical Digital Pathology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Clinical Digital Pathology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Digital Pathology Players in Global Market
3.6.1 List of Global Tier 1 Clinical Digital Pathology Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Digital Pathology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Clinical Digital Pathology Market Size Markets, 2022 & 2029
4.1.2 Whole Slide Imaging (WSI)
4.1.3 Image Analysis
4.1.4 Other
4.2 By Type – Global Clinical Digital Pathology Revenue & Forecasts
4.2.1 By Type – Global Clinical Digital Pathology Revenue, 2018-2023
4.2.2 By Type – Global Clinical Digital Pathology Revenue, 2024-2029
4.2.3 By Type – Global Clinical Digital Pathology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Clinical Digital Pathology Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Diagnostic Centers
5.2 By Application – Global Clinical Digital Pathology Revenue & Forecasts
5.2.1 By Application – Global Clinical Digital Pathology Revenue, 2018-2023
5.2.2 By Application – Global Clinical Digital Pathology Revenue, 2024-2029
5.2.3 By Application – Global Clinical Digital Pathology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Clinical Digital Pathology Market Size, 2022 & 2029
6.2 By Region – Global Clinical Digital Pathology Revenue & Forecasts
6.2.1 By Region – Global Clinical Digital Pathology Revenue, 2018-2023
6.2.2 By Region – Global Clinical Digital Pathology Revenue, 2024-2029
6.2.3 By Region – Global Clinical Digital Pathology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Clinical Digital Pathology Revenue, 2018-2029
6.3.2 US Clinical Digital Pathology Market Size, 2018-2029
6.3.3 Canada Clinical Digital Pathology Market Size, 2018-2029
6.3.4 Mexico Clinical Digital Pathology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Clinical Digital Pathology Revenue, 2018-2029
6.4.2 Germany Clinical Digital Pathology Market Size, 2018-2029
6.4.3 France Clinical Digital Pathology Market Size, 2018-2029
6.4.4 U.K. Clinical Digital Pathology Market Size, 2018-2029
6.4.5 Italy Clinical Digital Pathology Market Size, 2018-2029
6.4.6 Russia Clinical Digital Pathology Market Size, 2018-2029
6.4.7 Nordic Countries Clinical Digital Pathology Market Size, 2018-2029
6.4.8 Benelux Clinical Digital Pathology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Clinical Digital Pathology Revenue, 2018-2029
6.5.2 China Clinical Digital Pathology Market Size, 2018-2029
6.5.3 Japan Clinical Digital Pathology Market Size, 2018-2029
6.5.4 South Korea Clinical Digital Pathology Market Size, 2018-2029
6.5.5 Southeast Asia Clinical Digital Pathology Market Size, 2018-2029
6.5.6 India Clinical Digital Pathology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Clinical Digital Pathology Revenue, 2018-2029
6.6.2 Brazil Clinical Digital Pathology Market Size, 2018-2029
6.6.3 Argentina Clinical Digital Pathology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Clinical Digital Pathology Revenue, 2018-2029
6.7.2 Turkey Clinical Digital Pathology Market Size, 2018-2029
6.7.3 Israel Clinical Digital Pathology Market Size, 2018-2029
6.7.4 Saudi Arabia Clinical Digital Pathology Market Size, 2018-2029
6.7.5 UAE Clinical Digital Pathology Market Size, 2018-2029
7 Clinical Digital Pathology Companies Profiles
7.1 Leica Biosystems
7.1.1 Leica Biosystems Company Summary
7.1.2 Leica Biosystems Business Overview
7.1.3 Leica Biosystems Clinical Digital Pathology Major Product Offerings
7.1.4 Leica Biosystems Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.1.5 Leica Biosystems Key News & Latest Developments
7.2 ZEISS
7.2.1 ZEISS Company Summary
7.2.2 ZEISS Business Overview
7.2.3 ZEISS Clinical Digital Pathology Major Product Offerings
7.2.4 ZEISS Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.2.5 ZEISS Key News & Latest Developments
7.3 Hamamatsu Photonics
7.3.1 Hamamatsu Photonics Company Summary
7.3.2 Hamamatsu Photonics Business Overview
7.3.3 Hamamatsu Photonics Clinical Digital Pathology Major Product Offerings
7.3.4 Hamamatsu Photonics Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.3.5 Hamamatsu Photonics Key News & Latest Developments
7.4 3DHISTECH Ltd.
7.4.1 3DHISTECH Ltd. Company Summary
7.4.2 3DHISTECH Ltd. Business Overview
7.4.3 3DHISTECH Ltd. Clinical Digital Pathology Major Product Offerings
7.4.4 3DHISTECH Ltd. Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.4.5 3DHISTECH Ltd. Key News & Latest Developments
7.5 OLYMPUS (EVIDENT)
7.5.1 OLYMPUS (EVIDENT) Company Summary
7.5.2 OLYMPUS (EVIDENT) Business Overview
7.5.3 OLYMPUS (EVIDENT) Clinical Digital Pathology Major Product Offerings
7.5.4 OLYMPUS (EVIDENT) Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.5.5 OLYMPUS (EVIDENT) Key News & Latest Developments
7.6 Philipes
7.6.1 Philipes Company Summary
7.6.2 Philipes Business Overview
7.6.3 Philipes Clinical Digital Pathology Major Product Offerings
7.6.4 Philipes Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.6.5 Philipes Key News & Latest Developments
7.7 ROCHE
7.7.1 ROCHE Company Summary
7.7.2 ROCHE Business Overview
7.7.3 ROCHE Clinical Digital Pathology Major Product Offerings
7.7.4 ROCHE Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.7.5 ROCHE Key News & Latest Developments
7.8 KFBIO
7.8.1 KFBIO Company Summary
7.8.2 KFBIO Business Overview
7.8.3 KFBIO Clinical Digital Pathology Major Product Offerings
7.8.4 KFBIO Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.8.5 KFBIO Key News & Latest Developments
7.9 Motic
7.9.1 Motic Company Summary
7.9.2 Motic Business Overview
7.9.3 Motic Clinical Digital Pathology Major Product Offerings
7.9.4 Motic Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.9.5 Motic Key News & Latest Developments
7.10 Shengqiang
7.10.1 Shengqiang Company Summary
7.10.2 Shengqiang Business Overview
7.10.3 Shengqiang Clinical Digital Pathology Major Product Offerings
7.10.4 Shengqiang Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.10.5 Shengqiang Key News & Latest Developments
7.11 Unic
7.11.1 Unic Company Summary
7.11.2 Unic Business Overview
7.11.3 Unic Clinical Digital Pathology Major Product Offerings
7.11.4 Unic Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.11.5 Unic Key News & Latest Developments
7.12 Winmedic
7.12.1 Winmedic Company Summary
7.12.2 Winmedic Business Overview
7.12.3 Winmedic Clinical Digital Pathology Major Product Offerings
7.12.4 Winmedic Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.12.5 Winmedic Key News & Latest Developments
7.13 Wisleap
7.13.1 Wisleap Company Summary
7.13.2 Wisleap Business Overview
7.13.3 Wisleap Clinical Digital Pathology Major Product Offerings
7.13.4 Wisleap Clinical Digital Pathology Revenue in Global Market (2018-2023)
7.13.5 Wisleap Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer